Results 121 to 130 of about 52,048 (217)
YKP1447, A Novel Potential Atypical Antipsychotic Agent [PDF]
, 2009 Seon Min Dong +5 more
openalex +1 more source
Atypical Antipsychotic Use in Patients With Dementia: Managing Safety Concerns
, 2012 Martin H. Steinberg +1 more
openalex +2 more sources
Re: Atypical Antipsychotics Mechanisms of Action [PDF]
, 2003 Joseph H. Friedman
openalex +1 more source
Cost-Offsets of New Medications for Treatment of Schizophrenia [PDF]
Broad claims are frequently made that new medications will offset all or part of their costs by reducing other areas of Medicaid spending. In this paper we examine the net impact on spending for new drugs used to treat schizophrenia.
Richard G. Frank +2 more
core
RETRACTED ARTICLE: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis [PDF]
, 2015 Lin Tan +8 more
openalex +1 more source
Forget community care - reinstitutionalisation is here [PDF]
, 2002 Priebe, S, Turner, T
core +1 more source
VALID GROUNDS FOR THE SWITCH OF ORIGINAL ANTIPSYCHOTICS WITH GENERICS [PDF]
, 2010 Patients\u27 non-compliance in treatments, such as irregular taking of medication, represents an enormous problem with psychiatric patients in general.
Elizabeta Dadić-Hero +4 more
core +1 more source
Pediatric Obesity: Influence on Drug Dosing and Therapeutics [PDF]
, 2018 Obesity is an ongoing global health concern and has only recently been recognized as a chronic disease of energy homeostasis and fuel partitioning. Obesity afflicts 17% of US children and adolescents.
Ameer, Barbara, PharmD, MBA, BCPS, FCP +1 more
core +1 more source
Neuropsychopharmacology ReportsAims To investigate the negative attitudes of Japanese psychiatrists toward atypical long‐acting injectable (LAI) antipsychotics, which are the current mainstream LAIs in Japan.
Yoshiyo Oguchi +2 more
doaj +1 more source